Author:
Belova A. N.,Rasteryaeva M. V.,Zhulina N. I.,Belova E. M.,Boyko A. N.
Publisher
Media Sphere Publishing Group
Subject
Psychiatry and Mental health,Clinical Neurology
Reference124 articles.
1. Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
2. Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities
3. Matievskaya NV. Immune reconstitution inflammatory syndrome in HIV-infected patients: risk factors, clinical manifestations, outcomes, prevention. Bulletin of the Baltic Federal University named after Kant. 2012;7:44-51. (In Russ.).
4. Shelburne SA, Visnegarwalaa F, Darcourtc J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):-399-406.
5. Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, Longuet P, Leport C, Vildé JL. Determinants of Immune Reconstitution Inflammatory Syndrome in HIV Type 1-Infected Patients with Tuberculosis after Initiation of Antiretroviral Therapy. Clinical Infectious Diseases. 2004;39:1709-1712.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献